Keywords: synta, gets, 440m, funding, roche, usa-headquartered, pharmaceuticals

Synta gets $440M R&D funding from Roche

Article | 19 January 2009

USA-headquartered Synta Pharmaceuticals and Swiss drug major Roche have entered into a strategic alliance to discover, develop, and commercialize small-molecule ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing